Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated April 16, 2024, titled "Press Release on USFDA approval on Ofloxacin Ophthalmic Solution ANDA".
Press Release Apr 16 2024
Filed with NSE ·
6ix hasn’t read this filing yet.
Caplin Point Laboratories Limited on 6ix
Earlier from Caplin Point Laboratories
- Press Release Mar 28 2024
- Press Release Jan 08 2024
- Press Release (Revised) Sep 20 2023
- Press Release Sep 20 2023
- Press Release Sep 04 2023
Later from Caplin Point Laboratories
- Press Release May 06 2024
- Press Release May 24 2024
- Press Release Jul 19 2024
- Press Release Aug 08 2024
- Press Release Dec 16 2024
Follow Caplin Point Laboratories into a list and get an email when it puts out news.
Follow Caplin Point Laboratories